Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from REMR: Identification of RNA Editing-mediated MiRNA Regulation in Cancers. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1111/j.1574-6976.1999.tb00401.x
10.1111/j.1574-6976.1999.tb00401.x · External reference
10.1038/nrm.2015.4
10.1038/nrm.2015.4 · External reference
Rewriting the transcriptome: adenosine-to-inosine RNA editing by ADARs
10.1186/s13059-017-1347-3 · 2017 · External reference
10.1016/j.tig.2019.09.004
10.1016/j.tig.2019.09.004 · External reference
10.1016/j.ccell.2018.03.026
10.1016/j.ccell.2018.03.026 · External reference
10.1038/nrc.2017.23
10.1038/nrc.2017.23 · External reference
10.1016/j.celrep.2015.08.080
10.1016/j.celrep.2015.08.080 · External reference
REDIportal: millions of novel A-to-I RNA editing events from thousands of RNAseq experiments
10.1093/nar/gkaa916 · 2021 · External reference
10.1016/j.ccell.2015.08.013
10.1016/j.ccell.2015.08.013 · External reference
Genomic landscape and potential regulation of RNA editing in drug resistance
2023 · External reference
ADAR1-mediated RNA editing links ganglioside catabolism to glioblastoma stem cell maintenance
10.1172/jci143397 · 2022 · External reference
ADAR1-mediated RNA editing of SCD1 drives drug resistance and self-renewal in gastric cancer
10.1038/s41467-023-38581-8 · 2023 · External reference
The role of A-to-I RNA editing in cancer development
10.1016/j.gde.2017.10.009 · 2018 · External reference
10.1038/nrg2843
10.1038/nrg2843 · External reference
10.1038/nature02871
10.1038/nature02871 · External reference
10.1146/annurev.pathol.4.110807.092222
10.1146/annurev.pathol.4.110807.092222 · External reference
10.1016/j.devcel.2010.03.010
10.1016/j.devcel.2010.03.010 · External reference
10.1007/s00018-018-2940-7
10.1007/s00018-018-2940-7 · External reference
10.1093/nar/gkw550
10.1093/nar/gkw550 · External reference
10.1101/gr.133991.111
10.1101/gr.133991.111 · External reference
10.1016/j.ccell.2018.11.017
10.1016/j.ccell.2018.11.017 · External reference
10.1074/jbc.m117.775684
10.1074/jbc.m117.775684 · External reference
ADAR1-mediated 3′ UTR editing and expression control of antiapoptosis genes fine-tunes cellular apoptosis response
2017 · External reference
Altered RNA editing in 3′ UTR perturbs microRNA-mediated regulation of oncogenes and tumor-suppressors
2016 · External reference
10.1016/j.celrep.2019.02.084
10.1016/j.celrep.2019.02.084 · External reference
Systematical analysis of lncRNA-mRNA competing endogenous RNA network in breast cancer subtypes
10.1007/s10549-018-4678-1 · 2018 · External reference
10.1093/nar/gkq603
10.1093/nar/gkq603 · External reference
10.7554/elife.05005
10.7554/elife.05005 · External reference
clusterProfiler 4.0: a universal enrichment tool for interpreting omics data
2021 · External reference
miEAA 2023: updates, new functional microRNA sets and improved enrichment visualizations
10.1093/nar/gkad392 · 2023 · External reference
Network-based prediction of drug combinations
10.1038/s41467-019-09186-x · 2019 · External reference
An automated method for finding molecular complexes in large protein interaction networks
10.1186/1471-2105-4-2 · 2003 · External reference
10.1093/nar/gkac812
10.1093/nar/gkac812 · External reference
LncMAP: Pan-cancer atlas of long noncoding RNA-mediated transcriptional network perturbations
10.1093/nar/gkx1311 · 2018 · External reference
A double-stranded RNA unwinding activity introduces structural alterations by means of adenosine to inosine conversions in mammalian cells and Xenopus eggs
10.1073/pnas.86.8.2647 · 1989 · External reference
10.1016/0092-8674(88)90253-x
10.1016/0092-8674(88)90253-x · External reference
miRTarBase update 2022: an informative resource for experimentally validated miRNA-target interactions
10.1093/nar/gkab1079 · 2022 · External reference
DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA-gene interactions
10.1093/nar/gkx1141 · 2018 · External reference
10.1038/sj.cdd.4401826
10.1038/sj.cdd.4401826 · External reference
10.1038/s41388-018-0280-6
10.1038/s41388-018-0280-6 · External reference
Cathepsin S (CTSS) activity in health and disease - a treasure trove of untapped clinical potential
10.1016/j.mam.2022.101106 · 2022 · External reference
Cathepsin B: a sellsword of cancer progression
10.1016/j.canlet.2019.02.035 · 2019 · External reference
10.1038/bjc.2016.379
10.1038/bjc.2016.379 · External reference
10.1038/onc.2012.258
10.1038/onc.2012.258 · External reference
10.1101/gad.215939.113
10.1101/gad.215939.113 · External reference
10.1016/j.cell.2012.11.045
10.1016/j.cell.2012.11.045 · External reference
miEAA 2.0: integrating multi-species microRNA enrichment analysis and workflow management systems
10.1093/nar/gkaa309 · 2020 · External reference
miR-24-3p promotes colon cancer progression by targeting ING1
10.1038/s41392-020-0206-y · 2020 · External reference
miR-24 Inhibits cell proliferation by targeting E2F2, MYC, and other cell-cycle genes via binding to "seedless" 3′UTR microRNA recognition elements
10.1016/j.molcel.2009.08.020 · 2009 · External reference
10.1146/annurev-biochem-060308-103103
10.1146/annurev-biochem-060308-103103 · External reference
RNA editing contributes to epitranscriptome diversity in chronic lymphocytic leukemia
10.1038/s41375-020-0995-6 · 2021 · External reference
Dynamic inosinome profiles reveal novel patient stratification and gender-specific differences in glioblastoma
10.1186/s13059-019-1647-x · 2019 · External reference
The novel MDM4 inhibitor CEP-1347 activates the p53 pathway and blocks malignant meningioma growth in vitro and in vivo
10.3390/biomedicines11071967 · 2023 · External reference
c-Src-mediated phosphorylation and activation of kinesin KIF1C promotes elongation of invadopodia in cancer cells
10.1016/j.jbc.2022.102090 · 2022 · External reference
RNA editing of SLC22A3 drives early tumor invasion and metastasis in familial esophageal cancer
2017 · External reference
10.1158/1078-0432.ccr-15-2973
10.1158/1078-0432.ccr-15-2973 · External reference
MicroRNA-485-5p inhibits glioblastoma progression by suppressing E2F transcription factor 1 under cisplatin treatment
10.1080/21655979.2021.1982269 · 2021 · External reference
10.1002/ijc.28226
10.1002/ijc.28226 · External reference
Correction to: The regulatory ZFAS1/miR-150/ST6GAL1 crosstalk modulates sialylation of EGFR via PI3K/Akt pathway in T-cell acute lymphoblastic leukemia
10.1186/s13046-019-1365-y · 2019 · External reference
The regulatory ZFAS1/miR-150/ST6GAL1 crosstalk modulates sialylation of EGFR via PI3K/Akt pathway in T-cell acute lymphoblastic leukemia
10.1186/s13046-019-1208-x · 2019 · External reference
Genetic variation and microRNA targeting of A-to-I RNA editing fine tune human tissue transcriptomes
10.1186/s13059-021-02287-1 · 2021 · External reference
miR-146a-5p: expression, regulation, and functions in cancer
2019 · External reference
Microenvironmental regulation of cancer metastasis by miRNAs
10.1016/j.tcb.2013.09.007 · 2014 · External reference
